Evidence map›Paper›PMID 28919264›Full record

ArticleStem cell reports2017

Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action.

Kathleen A O'Leary, Michael P Shea, Stephanie Salituro, Courtney E Blohm, Linda A Schuler

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Prolactin: The Third Hormone in Breast Cancer.Frontiers in endocrinology · 2022
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Glycomics: Immunoglobulin GOmics : a journal of integrative biology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kathleen A O'LearyDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA.
Michael P SheaDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA; Molecular and Environmental Toxicology Graduate Program, University of Wisconsin-Madison, Madison, WI 53706, USA.
Stephanie SalituroDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA.
Courtney E BlohmDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA.
Linda A SchulerDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA; UW Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, WI 53792, USA; Molecular and Environmental Toxicology Graduate Program, University of Wisconsin-Madison, Madison, WI 53706, USA. Electronic address: linda.schuler@wisc.edu.
University of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
Molecular & Environmental Toxicology Pre-& Postdoctoral Training ProgramT32ES007015 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI CHRISTOPHER A BRADFIELD · 1985 to 2026
$11.5M
Matrix density promotes pro-tumorigenic hormone actions in breast cancerR01CA179556 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI PONIK, SUZANNE MARIE, SCHULER, LINDA A. · 2014 to 2024
$4.9M
Prolactin: mammary progenitors and tumor initiating cells in luminal carcinomasR01CA157675 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SCHULER, LINDA A. · 2011 to 2015
$1.5M
NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA157675NCI NIH HHS R01 CA179556NIEHS NIH HHS T32 ES007015
6 · The paper itself

Abstract

Hormones drive mammary development and function and play critical roles in breast cancer. Epidemiologic studies link prolactin (PRL) to increased risk for aggressive cancers that express estrogen receptor α (ERα). However, in contrast to ovarian steroids, PRL actions on the mammary gland outside of pregnancy are poorly understood. We employed the transgenic NRL-PRL model to examine the effects of PRL alone and with defined estrogen/progesterone exposure on stem/progenitor activity and regulatory networks that drive epithelial differentiation. PRL increased progenitors and modulated transcriptional programs, even without ovarian steroids, and with steroids further raised stem cell activity associated with elevated canonical Wnt signaling. However, despite facilitating some steroid actions, PRL opposed steroid-driven luminal maturation and increased CD61

Indexed as

Age FactorsAnimalsBiomarkersBreast NeoplasmsEpithelial CellsEstrogen Receptor alphaEstrogensFemaleGene ExpressionGonadal Steroid HormonesMammary Glands, AnimalMiceMice, TransgenicOvaryProgesteroneProlactinBiomarkersEstrogen Receptor alphaEstrogensGonadal Steroid HormonesProgesteroneProlactinReceptors, ProgesteroneSteroidsbreast cancerER+ breast cancerluminal progenitorsluminal subtypemammary epithelial cell subpopulationsmammary stem cellsprolactin

Identifiers

PMID28919264
PMCPMC5639259
OpenAlexW2755867134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.